MoneyWorks4Me

Asston Pharmaceuticals informs about disclosure

01 Sep 2026 Evaluate
Asston Pharmaceuticals has informed that it enclosed disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakruti R Pali.

The above information is a part of company’s filings submitted to BSE.

Asston Pharma Share Price

107.00 1.35 (1.28%)
04-Sep-2026 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.10
Dr. Reddys Labs. 1158.00
Cipla 1380.55
Lupin 2110.00
Zydus Lifesciences 1129.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: